SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

CRESCENT BIOPHARMA, INC. (CBIO)
Score window: May. 30, 2025 to May. 29, 2026

Back View Correspondence
Probe Score
2.5 / 10
Letters
1
Latest Activity
Jan. 13, 2026
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jan. 13, 2026 CORRESP Neutral/Informational Moderate Crescent Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. They are seeking to have the re… Read Filing EDGAR
Jan. 12, 2026 UPLOAD Concern from SEC Moderate The SEC has communicated to Crescent Biopharma, Inc. that they will not review the company's registration statement filed on January 7, 2026. The letter emphasizes the company's r… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.